Boceprevir and peginterferon α-2b plus ribavirin therapy of HCV genotype 3 relapsers: A pilot study

被引：0
|
作者：
Lee, Samuel S. [1 ]
Kilvert, Leah [1 ]
Liu, Hongqun [1 ]
Trepanier, Janie [2 ]
机构：
[1] Univ Calgary, Liver Unit, Calgary, AB, Canada
[2] Merck Canada, Montreal, PQ, Canada
来源：
DIGESTIVE AND LIVER DISEASE | 2016年 / 48卷 / 03期
关键词：
D O I：
10.1016/j.dld.2015.08.015
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：344 / 344
页数：1
相关论文
共 50 条
  • [21] Response-Guided Therapy With Boceprevir Plus Peginterferon Alfa-2B/Ribavirin Reduces Treatment Duration in NaiVE and Peginterferon Alfa-2B/Ribavirin Previous-Treatment-Failure Patients With HCV Genotype 1
    Manns, Michael P.
    Poordad, Fred
    Bacon, Bruce R.
    Bruno, Savino
    Esteban, Rafael
    Silva, Marcelo O.
    Buti, Maria
    Burroughs, Margaret
    Sniukiene, Vilma
    Boparai, Navdeep
    Brass, Cliflord A.
    Albrecht, Janice K.
    Bronowicki, Jean-Pierre
    GASTROENTEROLOGY, 2011, 140 (05) : S942 - S942
  • [22] Pegylated α interferon 2B plus ribavirin in the treatment of HCV genotype 4 infection
    Ghaffar, Tawhida Yassin Abdel
    El Naghy, Suzan
    El Sebaie, Hatem
    El Monaiery, Magda
    Ghaffar, Aisha Yassin Abdel
    INDIAN JOURNAL OF PEDIATRICS, 2009, 76 (09): : 895 - 898
  • [23] Pegylated α interferon 2B plus ribavirin in the treatment of HCV genotype 4 infection
    Tawhida Yassin Abdel Ghaffar
    Suzan El Naghy
    Hatem El Sebaie
    Magda El Monaiery
    Aisha Yassin Abdel Ghaffar
    The Indian Journal of Pediatrics, 2009, 76 : 895 - 898
  • [24] A PHASE 2B STUDY OF TELAPREVIR WITH PEGINTERFERON-ALFA-2A AND RIBAVIRIN IN HEPATITIS C GENOTYPE 1 NULL AND PARTIAL RESPONDERS AND RELAPSERS FOLLOWING A PRIOR COURSE OF PEGINTERFERON-ALFA-2A/B AND RIBAVIRIN THERAPY: PROVE3 INTERIM RESULTS
    McHutchison, John G.
    Shiffman, Mitchell L.
    Terrault, Norah
    Manns, Michael P.
    Di Bisceglie, Adrian M.
    Jacobson, Ira M.
    Afdhal, Nezom H.
    Heathcote, E. Jenny
    Zeuzem, Stefan
    Reesink, Hendrik W.
    George, Shelley
    Adda, Nathalie
    Muir, Andrew J.
    HEPATOLOGY, 2008, 48 (04) : 431A - 432A
  • [25] Randomized Study of Peginterferon-α2a Plus Ribavirin vs Peginterferon-α2b Plus Ribavirin in Chronic Hepatitis C
    Rumi, Maria Grazia
    Aghemo, Alessio
    Prati, Gian Maria
    D'Ambrosio, Roberta
    Donato, Maria Francesca
    Soffredini, Roberta
    Del Ninno, Ersilio
    Russo, Antonio
    Colombo, Massimo
    GASTROENTEROLOGY, 2010, 138 (01) : 108 - 115
  • [26] Peginterferon α-2b plus ribavirin compared with interferon α-2b plus ribavirin for initial treatment of chronic hepatitis C in Saudi patients commonly infected with genotype 4
    Alfaleh, FZ
    Hadad, Q
    Khuroo, MS
    Aljumah, A
    Algamedi, A
    Alashgar, H
    Al-Ahdal, MN
    Mayet, I
    Khan, MQ
    Kessie, G
    LIVER INTERNATIONAL, 2004, 24 (06) : 568 - 574
  • [27] SAFETY BENEFITS OF RESPONSE-GUIDED THERAPY WITH BOCEPREVIR (BOC) PLUS PEGINTERFERON ALFA-2B/RIBAVIRIN (PR) IN PREVIOUSLY UNTREATED PATIENTS WITH HCV GENOTYPE 1 INFECTION
    Manns, Michael P.
    McCone, Jonathan
    Davis, Mitchell
    Shiffman, Mitchell L.
    Rossaro, Lorenzo
    Bourliere, Marc
    Pedicone, Lisa
    Burroughs, Margaret
    Brass, Clifford A.
    Albrecht, Janice K.
    Bruno, Savino
    HEPATOLOGY, 2011, 54 : 813A - 813A
  • [28] OVERALL SAFETY PROFILE OF BOCEPREVIR PLUS PEGINTERFERON ALFA-2B/RIBAVIRIN
    Manns, M. P.
    Felizarta, F.
    Schiff, E.
    Burroughs, M.
    Sniukiene, V.
    Boparai, N.
    Brass, C. A.
    Albrecht, J. K.
    Vierling, J. M.
    JOURNAL OF HEPATOLOGY, 2011, 54 : S183 - S183
  • [29] Overall Safety Profile of Boceprevir Plus Peginterferon Alfa-2B/Ribavirin
    Manns, Michael P.
    Felizarta, Franco
    Schiff, Eugene R.
    Burroughs, Margaret
    Sniukiene, Vilma
    Boparai, Navdeep
    Brass, Clifford A.
    Albrecht, Janice K.
    Vierling, John M.
    GASTROENTEROLOGY, 2011, 140 (05) : S945 - S945
  • [30] Boceprevir-based triple therapy to rescue HCV genotype 1/HBV dually infected patients refractory to peginterferon plus ribavirin combination therapy in Taiwan
    Hsieh, Meng-Hsuan
    Yeh, Ming-Lun
    Su, Tung-Hung
    Liu, Ta-Wei
    Huang, Chuang-Feng
    Huang, Ching-I.
    Wang, Shu-Chi
    Huang, Jee-Fu
    Dai, Chia-Yen
    Kao, Jia-Horng
    Chuang, Wan-Long
    Chen, Pei-Jer
    Liu, Chun-Jen
    Yu, Ming-Lung
    JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION, 2018, 117 (06) : 497 - 504
12345